Dr. Philip McCarthy, Director of Blood & Marrow Transplant, describes this rare blood cancer and a major recent study he led involving treatment with the drug lenalidomide following stem-cell transplant. Steven Rukavina describes his experience with multiple myeloma: "[RPCI staff] made me feel like I was their only patient most of the time."
